跳至主要内容
临床试验/CTRI/2023/05/052752
CTRI/2023/05/052752尚未招募Unknown

EFFICACY OF COMBINATION OF MIDODRINE WITH WEEKLY ALBUMIN INFUSION VERSUS STANDARD MEDICAL THERAPY IN DECOMPENSATED LIVER CIRRHOSIS â?? A MULTICENTRIC STUDY

Mylan Pharmaceuticals Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All cirrhotic (sinusoidal portal hypertension) patients, age above 18 years, either gender, irrespective of aetiology, with refractoryascites, without acute kidney injury at the time of enrolment.

排除标准

  • Patients with
  • (i) cardiac conditions such as ischemic heart disease, congestive cardiac failure,
  • (ii) hepatic encephalopathy
  • (iii) active sepsis such as spontaneous bacterial peritonitis or blood culture positivity,
  • (iv) tuberculous ascites
  • (v) chronic kidney disease,
  • (vi) active malignancy
  • (vii) any contraindications to oral midodrine administration as listed above
  • (viii) any contraindications to intravenous albumin administration as listed above
  • (ix) not willing to participate in the study

研究者

发起方
Mylan Pharmaceuticals Pvt Ltd

相似试验

Midodrine plus albumin for ascites control | 临床试验